In January, Craig Williams, executive director of the Chemical Weapons Working Group based in Berea, Kentucky, insisted that the arsenal's stockpile was a prime candidate for neutralisation, a process planned for bulk chemical-agent stockpiles at the sites in Maryland and Indiana.
And Nucryst might apply its patented manufacturing process, which breaks the bulk silver down and then builds it back up atom by atom into silver nanocrystals, to other noble metals like gold and platinum for formulations to treat diseases as diverse as arthritis and cancer.